Senior insider sale
ATEA PHARMACEUTICALS, INC. — senior position signals high conviction
$1.02M
359.61K shares
What this filing means
BERGER FRANKLIN M plans to sell 359.61K shares of ATEA PHARMACEUTICALS, INC. valued at approximately $1.02M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/10/2024ACC: 0001968582-24-001157
Director
Since Oct 2020
359.61K
Shares to sell
$1.02M
Approx. market value
359.61K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months4
Investment
Funds Transfer
10/12/2020
35.47KInvestment
Funds Transfer
5/19/2020
60.54KInvestment
Funds Transfer
6/29/2018
131.58KInvestment
Funds Transfer
8/10/2016
132.01KTotal acquired359.61K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/12/2020 | Investment Funds Transfer | 35.47K | — |
5/19/2020 | Investment Funds Transfer | 60.54K | — |
6/29/2018 | Investment Funds Transfer | 131.58K | — |
8/10/2016 | Investment Funds Transfer | 132.01K | — |
| Total | 359.61K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
359.61K
Market value
$1.02M
12/10/2024
Total
Units
359.61K
Value
$1.02M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/10/2024 | 359.61K | $1.02M | Nasdaq | Planned |
| Total | 359.61K | $1.02M | ||